Besides FAM84A, ALKBH5 was reported to regulate alternative CSC targets, such as FOXM128,56, TACC334, and NANOG29, implying that multiple ALKBH5 downstream targets might collaterally contribute to stemness in CRC. This evidence concerns the gene ALKBH5 and colorectal carcinoma.